{
    "clinical_study": {
        "@rank": "122895", 
        "arm_group": {
            "arm_group_label": "Opiate abuser", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effects of treatment medications (methadone,\n      buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and\n      smoked heroin self-administration.\""
        }, 
        "brief_title": "A Laboratory Model for Heroin Abuse Medications - 8", 
        "completion_date": {
            "#text": "November 2005", 
            "@type": "Actual"
        }, 
        "condition": [
            "Heroin Dependence", 
            "Opioid-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heroin Dependence", 
                "Opioid-Related Disorders", 
                "Substance-Related Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "37", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000273", 
            "org_study_id": "#4857", 
            "secondary_id": [
                "5P50DA009236-18", 
                "P50 DA009236-08"
            ]
        }, 
        "intervention": {
            "arm_group_label": "Opiate abuser", 
            "description": "prescription opioids", 
            "intervention_name": "opiates", 
            "intervention_type": "Drug", 
            "other_name": [
                "morphine", 
                "fentanyl", 
                "buprenorphine", 
                "oxycodone", 
                "methadone"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Buprenorphine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "November 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10032"
                }, 
                "name": "Columbia University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Laboratory Model for Heroin Abuse Medications", 
        "overall_official": {
            "affiliation": "New York State Psychiatric Institute", 
            "last_name": "Herbert Kleber, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2005", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Amount drug self-administered", 
            "safety_issue": "No", 
            "time_frame": "90 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000273"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "17581533", 
            "citation": "Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology. 2008 Apr;33(5):1179-91. Epub 2007 Jun 20."
        }, 
        "secondary_outcome": {
            "measure": "Subjective responses", 
            "safety_issue": "No", 
            "time_frame": "90 min"
        }, 
        "source": "New York State Psychiatric Institute", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "New York State Psychiatric Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 1995", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }, 
    "geocoordinates": {
        "Columbia University": "40.714 -74.006"
    }
}